Pure Global AI
ANVISA registration 10159820274Valid until Mar 23, 2036

ANTI-HUMAN GLOBULIN (COOMBS)

ANVISA Registration Number: 10159820274EBRAM PRODUTOS LABORATORIAIS LTDAEBRAM PRODUTOS LABORATORIAIS LTDARisk Class III
Device names
Technical name
ANTI-HUMAN GLOBULIN (COOMBS)
PT: GLOBULINA ANTI-HUMANA (COOMBS)
Commercial name
Soro de Coombs
Risk class
Class III
Registration details
Registration Number
10159820274
Process Number
25351178573202555
CNPJ
50657402000131
Company information
Manufacturing Country
Brazil
PT: BRASIL
Dates and status
Publication Date
Mar 23, 2026
Validity
23/03/2036
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for ANTI-HUMAN GLOBULIN (COOMBS) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10159820274 and manufactured by EBRAM PRODUTOS LABORATORIAIS LTDA. The registration is held by EBRAM PRODUTOS LABORATORIAIS LTDA with validity until Mar 23, 2036.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.